Tongcheng Travel Shares Rise on Higher Net, Improved Outlook
By Jiahui Huang
Tongcheng Travel shares rose sharply in Hong Kong after the company reported a sharply higher net profit on improved revenue and as investors turned more upbeat on its outlook.
The Chinese travel company's shares rose 9.6% to 14.38 Hong Kong dollars, the equivalent of US$1.85, early Wednesday, on track for its largest one-day percentage gain in more than eight months.
The surge came after Tongcheng Travel's second-quarter net profit jumped on higher revenue and on analysts' positive outlook for its profitability in the second half of the year.
"Despite slower revenue growth assumption, we see enhanced earnings visibility ahead for Tongcheng for more quality growth," Citi analysts led by Brain Gong wrote in a note.
The company's plan to prioritize quality growth, referring to users of its Tongcheng travel app, may mean less subsidies will be needed for low quality users, especially those on WeChat, the analysts added. Its gross profit margin is also likely to improve sequentially thanks to higher sales and lower marketing expenses, they said.
Tongcheng Travel's second-quarter net profit rose 22%, compared with the same period a year earlier, to 433.7 million yuan, or US$60.8 million, while revenue rose 48% to 4.24 billion yuan.
Looking ahead, the company may book decent growth on hotel bookings and airline tickets in the third quarter, as it is the peak season for outbound travel in China, the analysts say.
Write to Jiahui Huang at jiahui.huang@wsj.com
(END) Dow Jones Newswires
August 21, 2024 00:03 ET (04:03 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks